US2021052500A1PendingUtilityA1
Multiparticulate formulations of cannabinoids
Est. expiryJul 18, 2038(~12 yrs left)· nominal 20-yr term from priority
A61K 36/3482A61K 31/658A61K 31/352A61P 1/14A61P 19/02A61P 25/06A61P 25/18A61P 25/08A61P 25/22A61P 25/24A61P 11/00A61P 1/08A61P 29/00A61K 31/353A61K 9/1611A61K 9/1652A61K 9/4808A61K 9/48A61K 9/0056A61K 9/2086A61K 9/0053A61K 9/1658A61K 9/1635A61K 9/1623A61K 9/1676A61K 9/1664A61K 9/009A61K 9/1617A61K 31/05A61K 36/185
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions for the immediate release, extended release, or sustained release of two or more active agents, in which the two or more active agents comprises at least one cannabinoid and at least one non-cannabinoid therapeutic agent. The compositions comprise a population of particles, in which each particles comprises the at least one cannabinoid, the at least one non-cannabinoid therapeutic agent, or a combination thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition for immediate release of two or more active agents, wherein the two or more active agents comprise at least one cannabinoid and at least one non-cannabinoid therapeutic agent,
the composition comprising a population of particles, wherein each particle comprises:
(a) the at least one cannabinoid, the at least one non-cannabinoid therapeutic agent, or a combination thereof;
(b) a porous bead core;
wherein the composition releases at least about 30% of the two or more actives over a period of about 30 minutes or less.
2 . The composition of claim 1 , wherein the porous bead core comprises a silica bead or porous biodegradable glass bead.
3 . A composition for sustained release of two or more active agents, wherein the two or more active agents comprise at least one cannabinoid and at least one non-cannabinoid therapeutic agent,
the composition comprising a combination of: (a) particles of the composition of claim 1 ; and (b) particles of an extended release composition of two or more active agents, wherein the two or more active agents of the extended release composition comprise at least one cannabinoid and at least one non-cannabinoid therapeutic agent, each particle of the extended release composition comprising:
(i) the at least one cannabinoid, the at least one non-cannabinoid therapeutic agent, or a combination thereof;
(ii) one or more drug releasing agents comprising one or more lipid-based gel-forming agents;
(iii) a core; and
(iv) one or more surfactants;
wherein the extended release composition releases the two or more actives over a period of at least 6 hours.
4 . A composition for sustained release of two or more active agents, wherein the two or more active agents comprise at least one cannabinoid and at least one non-cannabinoid therapeutic agent,
the composition comprising a combination of: (a) particles of the composition of claim 1 ; and (b) particles of an extended release composition of two or more active agents, wherein the two or more active agents of the extended release composition comprise at least one cannabinoid and at least one non-cannabinoid therapeutic agent, each particle of the extended release composition comprising:
(i) the at least one cannabinoid, the at least one non-cannabinoid therapeutic agent, or a combination thereof;
(ii) one or more drug releasing agents comprising one or more release-controlling polymers, one or more release-accelerating polymers, or a combination thereof; and
(iii) a core;
wherein the extended release composition releases the two or more actives over a period of at least 6 hours.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.